{"nct_id":"NCT01528345","title":"Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer","status":"TERMINATED","status_verified_date":"2016-05","start_date":"2012-04","start_date_type":null,"primary_completion_date":"2015-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}